about
Biotransformation of the antiviral drugs acyclovir and penciclovir in activated sludge treatment.Biological surface coating and molting inhibition as mechanisms of TiO2 nanoparticle toxicity in Daphnia magna.Oxidation of the antiviral drug acyclovir and its biodegradation product carboxy-acyclovir with ozone: kinetics and identification of oxidation products.Transformation of oxcarbazepine and human metabolites of carbamazepine and oxcarbazepine in wastewater treatment and sand filters.Electrochemical Transformation of Trace Organic Contaminants in the Presence of Halide and Carbonate IonsIs biological treatment a viable alternative for micropollutant removal in drinking water treatment processes?Spoilt for choice: A critical review on the chemical and biological assessment of current wastewater treatment technologies.Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle.Oxypurinol - A novel marker for wastewater contamination of the aquatic environment.Identification of transformation products of antiviral drugs formed during biological wastewater treatment and their occurrence in the urban water cycle.Exploring Trends of C and N Isotope Fractionation to Trace Transformation Reactions of Diclofenac in Natural and Engineered Systems.Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance?Environmental fate of the anthelmintic ivermectin in an aerobic sediment/water system.In response: what are the challenges and prospects? An academic perspective.Elimination of micropollutants and transformation products from a wastewater treatment plant effluent through pilot scale ozonation followed by various activated carbon and biological filters.Integrated Evaluation Concept to Assess the Efficacy of Advanced Wastewater Treatment Processes for the Elimination of Micropollutants and Pathogens.Occurrence and fate of amisulpride, sulpiride, and lamotrigine in municipal wastewater treatment plants with biological treatment and ozonation.Environmental risk assessment of ivermectin: A case study.Co-occurrence of Photochemical and Microbiological Transformation Processes in Open-Water Unit Process Wetlands.Why Small Differences Matter: Elucidation of the Mechanisms Underlying the Transformation of 2OH- and 3OH-Carbamazepine in Contact with Sand Filter Material.Unexpected transformation of dissolved phenols to toxic dicarbonyls by hydroxyl radicals and UV light.Oxidation of Benzene by Persulfate in the Presence of Fe(III)- and Mn(IV)-Containing Oxides: Stoichiometric Efficiency and Transformation Products.Assessing the photochemical transformation pathways of acetaminophen relevant to surface waters: Transformation kinetics, intermediates, and modellingBioaccumulation of ivermectin from natural and artificial sediments in the benthic organism Lumbriculus variegatusThe Role of Reactive Nitrogen Species in Sensitized Photolysis of Wastewater-Derived Trace Organic ContaminantsWhat you extract is what you see: Optimising the preparation of water and wastewater samples for in vitro bioassaysMicrobial degradation pathways of the herbicide bentazone in filter sand used for drinking water treatmentApplication of Orbitrap Mass Spectrometry for the Identification of Transformation Products of Trace Organic Contaminants Formed in the EnvironmentToxification by Transformation in Conventional and Advanced Wastewater Treatment: The Antiviral Drug AcyclovirContamination and source assessment of metals, polychlorinated biphenyls, and polycyclic aromatic hydrocarbons in urban soils from Addis Ababa, EthiopiaTranslocation of Sb and Ti in an undisturbed floodplain soil after application of Sb2O3 and TiO2 nanoparticles to the surfaceRemoval of Organic and Inorganic Pollutants and Pathogens from Wastewater and Drinking Water Using Nanoparticles – A ReviewChlorination of Phenols Revisited: Unexpected Formation of α,β-Unsaturated C4-Dicarbonyl Ring Cleavage ProductsRing-Cleavage Products Produced during the Initial Phase of Oxidative Treatment of Alkyl-Substituted Aromatic Compounds
P50
Q33841354-46DA69C6-4B71-4575-B0FD-CD9103376068Q33925319-23000CF3-E236-4B50-A3AE-5DFB28948BBFQ34149016-B2579507-9EC7-4D1D-93F6-98852FDC0857Q35228051-8AD516DB-3C70-413E-A5EE-CFC85818EDF1Q37274224-B620AA5A-997D-49D7-9862-B24BA9406013Q38140119-761AEB4B-2B73-41EA-853D-F2C1270C83ABQ38597915-15309BF1-738B-41CA-A651-0D92729785D7Q38837726-EB55D899-1BD7-4714-89DE-BA20B58BAAE6Q40262468-806E0941-6923-49C8-824D-48A19BEE5ABAQ40367217-85A6CB71-63DF-4AD9-8583-714C45AB0F9CQ40405430-1F15E7C4-CDBF-4865-8C6A-EB369ADCB941Q43182004-797B200F-F496-424F-9F15-31F112EEE97EQ43257365-185A05E2-FD0B-4399-A474-A827FBDE8DA9Q43324718-C2E6F8CF-A7FD-4B10-BD34-240616CC9F30Q43349970-C9D938AB-282A-4218-A985-60AD49595D26Q43357303-A5E124F4-DF8E-454A-B006-F846F8AC8DEBQ45216393-0F627EEC-8467-4897-8732-90692D4C83D3Q45356246-AA446CAD-9901-49D4-B223-52696D2FB97CQ46258470-016EDD54-9EB7-4598-9FBA-8EC67B574BC1Q46680121-23A1D554-CF68-4EA7-9D95-9A066DB2B8C9Q49790332-1CC115D9-CF70-4EE6-B613-9121038658C9Q51599529-DCA853AA-CFF9-4170-89F5-7471D7E05D07Q60434293-5D660A41-CE43-4D10-B2DC-CDD2CF2F3AC7Q60485311-F9FF3398-34D6-45CE-891C-04453BAF1879Q63943607-94FC18F3-53FC-4D36-AA57-1D3924CEE243Q63943610-8052BF0F-0015-449B-AD84-E0B7B952164EQ63943614-AA9BE60F-988C-419F-88D1-0389FF950139Q63943617-B0577F9A-E923-4025-B236-37D443C23A0FQ63943621-F43A6C16-3F16-48E5-8DD8-A37FAD4D8B18Q63943626-EB61ABF5-DDE1-45E5-AC88-378FE8AC840EQ63943629-F550A5F6-6315-4781-804D-72C4A5B5849FQ63943632-5E18DFD9-B4F2-4E3D-87BC-1032E6395415Q92436365-07E5F971-E543-4DB2-BE16-4CD8A0CAF8CAQ96233802-1057A797-FA3F-4FDB-B0EC-96F2D3A8FABD
P50
description
researcher ORCID ID = 0000-0002-1470-141X
@en
wetenschapper
@nl
name
Carsten Prasse
@ast
Carsten Prasse
@en
Carsten Prasse
@es
Carsten Prasse
@nl
type
label
Carsten Prasse
@ast
Carsten Prasse
@en
Carsten Prasse
@es
Carsten Prasse
@nl
prefLabel
Carsten Prasse
@ast
Carsten Prasse
@en
Carsten Prasse
@es
Carsten Prasse
@nl
P106
P1153
35488909000
P21
P31
P496
0000-0002-1470-141X